Preparation method of anti-nash drug intermediate dialdehyde group magnolol
A magnolol and dialdehyde-based technology, applied in the field of organic synthesis, can solve problems such as difficult separation and purification, low yield, and many by-products, and achieve the effects of being beneficial to industrial production, reducing production costs, and reducing reaction by-products
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] The preparation method of the anti-NASH drug intermediate dialdehyde group magnolol of the present embodiment, described method comprises the steps:
[0031] In a 50 ml round bottom flask, magnolol (1.064 g, 4.0 mmol) was added at room temperature. Weigh hexamethylenetetramine (1.1216g, 8.0mmol) and dissolve it in glacial acetic acid (2mL), add it together to the flask, slowly heat up to 130°C and stir for 3 hours, then cool down to 100°C, add sulfuric acid solution ( 33%, w / w, 0.2mL), continued to stir for 1 hour, cooled to room temperature, added diethyl ether to extract 3 times, washed with brine, dried over anhydrous sodium sulfate, and removed the solvent under reduced pressure to obtain a residue, which was separated by column chromatography (ethyl acetate ester / petroleum ether, 1:60) to obtain the target product 5,5'-diallyl-2,2'-dihydroxy-[1,1'-biphenyl]-3,3'-dicarbaldehyde, the yield 73.3%.
[0032] The HPLC detection result of the above-mentioned synthetic p...
Embodiment 2
[0036] The preparation method of the anti-NASH drug intermediate dialdehyde group magnolol of the present embodiment, described method comprises the steps:
[0037]In a 50 ml round bottom flask, magnolol (0.2660 g, 1.0 mmol) was added at room temperature. Weigh hexamethylenetetramine (0.0701g, 0.5mmol) and dissolve it in glacial acetic acid (2mL), add it together to the flask, slowly heat up to 130°C and stir for 3 hours, then cool down to 100°C, add sulfuric acid solution ( 33%, w / w, 2mL), continued to stir for 1 hour, cooled to room temperature, added diethyl ether to extract 3 times, washed with brine, dried over anhydrous sodium sulfate, and removed the solvent under reduced pressure to obtain a residue, which was separated by column chromatography (ethyl acetate / petroleum ether, 1:60) to obtain the target product 5,5'-diallyl-2,2'-dihydroxy-[1,1'-biphenyl]-3,3'-dicarbaldehyde in a yield of 76.2 %, the purity is 99.1% (HPLC detection wavelength: 254nm, mobile phase is 40...
Embodiment 3
[0039] The preparation method of the anti-NASH drug intermediate dialdehyde group magnolol of the present embodiment, described method comprises the steps:
[0040] In a 50 ml round bottom flask, magnolol (0.2660 g, 1.0 mmol) was added at room temperature. Weigh hexamethylenetetramine (0.2804g, 2.0mmol) and dissolve it in glacial acetic acid (2mL), add it to the flask together, slowly raise the temperature to 130°C and stir for 1 hour, then cool down to 100°C, add sulfuric acid solution ( 33%, w / w, 2mL), continued to stir for 1 hour, cooled to room temperature, added diethyl ether to extract 3 times, washed with brine, dried over anhydrous sodium sulfate, and removed the solvent under reduced pressure to obtain a residue, which was separated by column chromatography (ethyl acetate / petroleum ether, 1:60) to obtain the target product 5,5'-diallyl-2,2'-dihydroxy-[1,1'-biphenyl]-3,3'-dicarbaldehyde, the yield was 60.6 %, the purity is 98.9% (HPLC detection wavelength: 254nm, mob...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


